Patent application number | Description | Published |
20100204368 | FUNCTIONALIZED LIGNIN, RUBBER CONTAINING FUNCTIONALIZED LIGNIN AND PRODUCTS CONTAINING SUCH RUBBER COMPOSITION - The invention relates to functionalized lignin, rubber compositions which contain functionalized lignin and to products which have at least one component comprised of such rubber composition. | 08-12-2010 |
20110136939 | TIRE WITH COMPONENT CONTAINING CELLULOSE - The present invention is directed to a method of making a rubber composition, comprising the steps of mixing cellulose fibers and water to form a first mixture; mixing the first mixture with an aqueous diene-based elastomer latex to form a second mixture comprising cellulose fibers, elastomer, and water; and separating the cellulose fibers and elastomer from the water to form a elastomer/cellulose masterbatch. | 06-09-2011 |
20130032262 | TIRE WITH FOAMED NOISE DAMPER - The present invention is directed to a method for making a pneumatic tire having a foam noise damper, the pneumatic tire comprising two spaced inextensible beads; a ground contacting tread portion; a pair of individual sidewalls extending radially inward from the axial outer edges of said tread portion to join the respective beads, the axial outer edges of the tread portion defining a tread width; a supporting carcass for the tread portion and sidewalls; an innerliner disposed radially inward of the carcass, the innerliner having a innerliner surface facing an interior cavity of the tire; the method comprising the steps of:
| 02-07-2013 |
Patent application number | Description | Published |
20080233568 | Detection of Extracellular Tumor-Associated Nucleic Acid in Blood Plasma or Serum Using Nucleic Acid Amplification Assays - This invention relates to detection of specific extracellular nucleic acid in plasma or serum fractions of human or animal blood associated with neoplastic or proliferative disease. Specifically, the invention relates to detection of nucleic acid derived from mutant oncogenes or other tumor-associated DNA, and to those methods of detecting and monitoring extracellular mutant oncogenes or tumor-associated DNA found in the plasma or serum fraction of blood by using rapid DNA extraction followed by nucleic acid amplification with or without enrichment for mutant DNA. In particular, the invention relates to the detection, identification, or monitoring of the existence, progression or clinical status of benign, premalignant, or malignant neoplasms in humans or other animals that contain a mutation that is associated with the neoplasm through detection of the mutated nucleic acid of the neoplasm in plasma or serum fractions. The invention permits the detection of extracellular, tumor-associated nucleic acid in the serum or plasma of humans or other animals recognized as having a neoplastic or proliferative disease or in individuals without any prior history or diagnosis of neoplastic or proliferative disease. The invention provides the ability to detect extracellular nucleic acid derived from genetic sequences known to be associated with neoplasia, such as oncogenes, as well as genetic sequences previously unrecognized as being associated with neoplastic or proliferative disease. The invention thereby provides methods for early identification of colorectal, pancreatic, lung, breast, bladder, ovarian, lymphoma and all other malignancies carrying tumor-related mutations of DNA and methods for monitoring cancer and other neoplastic disorders in humans and other animals. | 09-25-2008 |
20080233569 | Detection of Extracellular Tumor-Associated Nucleic Acid in Blood Plasma or Serum Using Nucleic Acid Amplification Assays - This invention relates to detection of specific extracellular nucleic acid in plasma or serum fractions of human or animal blood associated with neoplastic or proliferative disease. Specifically, the invention relates to detection of nucleic acid derived from mutant oncogenes or other tumor-associated DNA, and to those methods of detecting and monitoring extracellular mutant oncogenes or tumor-associated DNA found in the plasma or serum fraction of blood by using rapid DNA extraction followed by nucleic acid amplification with or without enrichment for mutant DNA. In particular, the invention relates to the detection, identification, or monitoring of the existence, progression or clinical status of benign, premalignant, or malignant neoplasms in humans or other animals that contain a mutation that is associated with the neoplasm through detection of the mutated nucleic acid of the neoplasm in plasma or serum fractions. The invention permits the detection of extracellular, tumor-associated nucleic acid in the serum or plasma of humans or other animals recognized as having a neoplastic or proliferative disease or in individuals without any prior history or diagnosis of neoplastic or proliferative disease. The invention provides the ability to detect extracellular nucleic acid derived from genetic sequences known to be associated with neoplasia, such as oncogenes, as well as genetic sequences previously unrecognized as being associated with neoplastic or proliferative disease. The invention thereby provides methods for early identification of colorectal, pancreatic, lung, breast, bladder, ovarian, lymphoma and all other malignancies carrying tumor-related mutations of DNA and methods for monitoring cancer and other neoplastic disorders in humans and other animals. | 09-25-2008 |
20090298085 | Detection of Extracellular Tumor-Associated Nucleic Acid in Blood Plasma or Serum Using Nucleic Acid Amplification Assays - This invention relates to detection of specific extracellular nucleic acid in plasma or serum fractions of human or animal blood associated with neoplastic or proliferative disease. Specifically, the invention relates to detection of nucleic acid derived from mutant oncogenes or other tumor-associated DNA, and to those methods of detecting and monitoring extracellular mutant oncogenes or tumor-associated DNA found in the plasma or serum fraction of blood by using rapid DNA extraction followed by nucleic acid amplification with or without enrichment for mutant DNA. In particular, the invention relates to the detection, identification, or monitoring of the existence, progression or clinical status of benign, premalignant, or malignant neoplasms in humans or other animals that contain a mutation that is associated with the neoplasm through detection of the mutated nucleic acid of the neoplasm in plasma or serum fractions. The invention permits the detection of extracellular, tumor-associated nucleic acid in the serum or plasma of humans or other animals recognized as having a neoplastic or proliferative disease or in individuals without any prior history or diagnosis of neoplastic or proliferative disease. The invention provides the ability to detect extracellular nucleic acid derived from genetic sequences known to be associated with neoplasia, such as oncogenes, as well as genetic sequences previously unrecognized as being associated with neoplastic or proliferative disease. The invention thereby provides methods for early identification of colorectal, pancreatic, lung, breast, bladder, ovarian, lymphoma and all other malignancies carrying tumor-related mutations of DNA and methods for monitoring cancer and other neoplastic disorders in humans and other animals. | 12-03-2009 |
Patent application number | Description | Published |
20100079369 | Using Physical Objects in Conjunction with an Interactive Surface - An interaction management module (IMM) is described for allowing users to engage an interactive surface in a collaborative environment using various input devices, such as keyboard-type devices and mouse-type devices. The IMM displays digital objects on the interactive surface that are associated with the devices in various ways. The digital objects can include input display interfaces, cursors, soft-key input mechanisms, and so on. Further, the IMM provides a mechanism for establishing a frame of reference for governing the placement of each cursor on the interactive surface. Further, the IMM provides a mechanism for allowing users to make a digital copy of a physical article placed on the interactive surface. The IMM also provides a mechanism which duplicates actions taken on the digital copy with respect to the physical article, and vice versa. | 04-01-2010 |
20120212509 | Providing an Interactive Experience Using a 3D Depth Camera and a 3D Projector - An interaction system is described which uses a depth camera to capture a depth image of a physical object placed on, or in vicinity to, an interactive surface. The interaction system also uses a video camera to capture a video image of the physical object. The interaction system can then generate a 3D virtual object based on the depth image and video image. The interaction system then uses a 3D projector to project the 3D virtual object back onto the interactive surface, e.g., in a mirrored relationship to the physical object. A user may then capture and manipulate the 3D virtual object in any manner. Further, the user may construct a composite model based on smaller component 3D virtual objects. The interaction system uses a projective texturing technique to present a realistic-looking 3D virtual object on a surface having any geometry. | 08-23-2012 |
20130229353 | Using Physical Objects in Conjunction with an Interactive Surface - An interaction management module (IMM) is described for allowing users to engage an interactive surface in a collaborative environment using various input devices, such as keyboard-type devices and mouse-type devices. The IMM displays digital objects on the interactive surface that are associated with the devices in various ways. The digital objects can include input display interfaces, cursors, soft-key input mechanisms, and so on. Further, the IMM provides a mechanism for establishing a frame of reference for governing the placement of each cursor on the interactive surface. Further, the IMM provides a mechanism for allowing users to make a digital copy of a physical article placed on the interactive surface. The IMM also provides a mechanism which duplicates actions taken on the digital copy with respect to the physical article, and vice versa. | 09-05-2013 |
Patent application number | Description | Published |
20090003484 | DEVICE AND METHOD FOR COMMUNICATION USING HYBRID MODULATION - A method and system for modulating a signal includes providing a carrier including periodic waves, peaks of the periodic waves defining a carrier shape of the carrier; changing a plurality of the periodic waves so that peaks of the changed waves form a shaped signal having a signal shape which is different from the carrier shape; and detecting the shaped signal. | 01-01-2009 |
20130246050 | VOICE CONTROL OF APPLICATIONS BY ASSOCIATING USER INPUT WITH ACTION-CONTEXT IDENTIFIER PAIRS - A method is provided for enabling or enhancing a use of voice control in a voice controlled application (VCA) via a development framework. The method includes: providing in the framework a plurality of action-context pairs—also called framework action-context pairs—usable in a memory of an application development device, which includes a processor, that serve to direct execution of the VCA, wherein the framework context defines a list of parameters related to the action and their respective value types; providing at least one of a voice recognition engine (VRE) and a natural language library to match each action-context pair with semantically related vocabulary; providing in the framework a registration mechanism that permits an association to be formed between an action-context pair and a handler in the voice controlled application. An associated development system for developing the VCA and user equipment that executes the VCA are provided as well. | 09-19-2013 |
20140297288 | TELEPHONE VOICE PERSONAL ASSISTANT - A system and associated method are provided for using a voice activated voice personal assistant (VPA) for a first user equipment, comprising: detecting establishment of a voice communication with a second user equipment; monitoring the voice communications using the VPA for commands relevant to the VPA; identifying, by the VPA, the commands within the voice communication; and implementing an action related to the commands during the ongoing voice communication. | 10-02-2014 |